Nuage
Founded 2021 · 23 employees on LinkedIn · 3 known investors
Nuage develops drug discovery technology targeting intrinsically disordered proteins in cancer, focusing on oncogenic transcription factors previously inaccessible to conventional drug discovery approaches. The company also explores applications in neurodegenerative diseases and autoimmune disorders.
Investors · 3
Frequently asked questions
- What does Nuage do?
- Nuage develops drug discovery technology targeting intrinsically disordered proteins in cancer, focusing on oncogenic transcription factors previously inaccessible to conventional drug discovery approaches. The company also explores applications in neurodegenerative diseases and autoimmune disorders.
- Who are Nuage's investors?
- Nuage's investors include BStartup, Sofinnova Partners, Asabys Partners.